149th ENMC International Workshop and 1st TREAT-NMD Workshop on: "planning phase i/ii clinical trials using systemically delivered antisense oligonucleotides in duchenne muscular dystrophy". (Q37061270)

From Wikidata
Revision as of 13:01, 12 June 2024 by Emijrpbot (talk | contribs) (‎Changed label, description and/or aliases in fr, pt, da: BOT - Fixing descriptions (3 languages): da, fr, pt)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
scientific article published on 22 January 2008
edit
Language Label Description Also known as
English
149th ENMC International Workshop and 1st TREAT-NMD Workshop on: "planning phase i/ii clinical trials using systemically delivered antisense oligonucleotides in duchenne muscular dystrophy".
scientific article published on 22 January 2008

    Statements

    title
    149th ENMC International Workshop and 1st TREAT-NMD Workshop on: "planning phase i/ii clinical trials using systemically delivered antisense oligonucleotides in duchenne muscular dystrophy". (English)
    1 reference
    stated in
    Europe PubMed Central
    PubMed publication ID
    18207401
    retrieved
    18 August 2017
    main subject
    phase I clinical trial
    0 references
    workshop
    0 references

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit
                      Retrieved from "https://www.wikidata.org/w/index.php?title=Q37061270&oldid=2177306625"